Indian Immunologicals Ltd
About Indian Immunologicals Ltd
Categories
-
IN -
2019On CPHI since
-
1000 - 4999Employees
Company types
Contact info
-
-
-
Road No 44, Jubilee Hills, 500 033, Hyderabad, India
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Products from Indian Immunologicals Ltd (5)
-
Product ABHAYRAB
Abhayrab is a purified Inactivated Rabies Vaccine prepared on Vero cells and is used for the prophylactic or post exposure immunization against Rabies. The vaccine is prepared using L.Pasteur 2061/Vero Rabies strain and is exported widely to 40 countries worldwide. Each pack consists of 1 dose vial along w... -
Product ELOVAC-B
Elovac-B (Recombinant Hepatitis - B vaccine) is a non infectious recombinant DNA vaccine. It is a sterile suspension of purified major surface antigen of Hepatitis B virus (HBV). Elovac-B Vaccine is indicated for immunization against infection caused by all known sub-types of Hepatitis B virus. Elovac... -
Product RAKSHARAB
Raksharab is recommended for immunization of dogs against rabies and contains inactivated rabies virus. The virus is propagated in BHK-21 Cell line, inactivated with an aziridine compound and concentrated. Single dose vial : 1 ml Multidose vial containing 5 doses : 5 ml Multidose vial containi... -
Product Abhay-TAG
Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) is a sterile, whitish turbid, uniform suspension of diphtheria, tetanus toxoids and pertussis vaccine adsorbed on Aluminium phosphate and Thiomersal (0.01%) is used as preservative. Abhay-TAGTM Vaccine is indicated for the primary immunization against di... -
Product Abhay-TOX
Abhay - TOXTM Tetanus Vaccine (Adsorbed) manufactured by Human Biologicals Institute, for intramuscular injection, is a sterile suspension of Aluminium phosphate adsorbed tetanus toxoid in isotonic sodium chloride solution.
Indian Immunologicals Ltd Resources (2)
-
News COVID-19 VACCINE DEVELOPMENT
Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world.
Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance